Protara Therapeutics

ArTara Therapeutics is a Biotechnology company.

Launch date

Jan 2006

Employees

Market cap

Enterprise valuation

(CAD62m) (Public information from Sep 2024)

New York City New York (HQ)

https://protaratx.com/

https://www.linkedin.com/company/protara-therapeutics/

Revenues, earnings & profits over time

USD	2018	2019	2020	2021	2022	2023	2024
Revenues	-	-	-	-	-	-	1.1m
EBITDA	(21.3m)	(15.2m)	(34.2m)	(47.3m)	(8.0m)	(43.3m)	-
Profit	(20.7m)	(15.0m)	(34.0m)	(47.3m)	(66.0m)	(40.4m)	-
R&D budget	11.8m	6.4m	12.0m	21.1m	16.8m	25.0m	-

Date	Investors	Amount	Round
-	Abingworth TVM Capital Life Science	N/A	-
Dec 2014	N/A	N/A	IPO
Jan 2018	N/A	$4.2m	Post IPO Equity
Apr 2024*	RA Capital Management Boxer Capital Acorn Bioventures Catalio Capital Management Woodline Partners Armistice Capital StemPoint Capital Velan Capital	$45.0m	Private Placement VC
Total Funding		CAD61.4m

Tech stackLearn more about the technologies and tools that this company uses.